Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow
The
Dow Jones Industrial Average
(
^DJI
) is trading up 18 points (+0.1%) at 12,956 as of Thursday, Feb 23, 2012, 10:35 a.m. ET. During this time, 170.6 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 818.6 million. The NYSE advances/declines ratio sits at 1,661 issues advancing vs. 1,113 declining with 145 unchanged.
Friday, February 24, 2012 is the ex-dividend date for Dow component
(NYSE:
). Owners of shares as of market close today will be eligible for a dividend of 57 cents per share. At a price of $65.03 as of 10:35 a.m. ET, the dividend yield is 3.5% compared to the average Dow component yield of 2.7%.
- See our dividend calendar or top-yielding stocks list.
The average volume for Johnson & Johnson has been 10.7 million shares per day over the past 30 days. Johnson & Johnson has a market cap of $177.51 billion and is part of the
sector and
industry. Shares are down 0.9% year to date as of Wednesday's close.
Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The company has a P/E ratio of 13, below the average drugs industry P/E ratio of 15.9 and below the S&P 500 P/E ratio of 17.7.
- Practice your dividend trading strategies and win cash in our stock game.
TheStreet Ratings rates Johnson & Johnson as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full Johnson & Johnson Ratings Report.
null
